EE9600147A - Kapseldatud rakkude peremeeslooma implanteerimise meetod - Google Patents
Kapseldatud rakkude peremeeslooma implanteerimise meetodInfo
- Publication number
- EE9600147A EE9600147A EE9600147A EE9600147A EE9600147A EE 9600147 A EE9600147 A EE 9600147A EE 9600147 A EE9600147 A EE 9600147A EE 9600147 A EE9600147 A EE 9600147A EE 9600147 A EE9600147 A EE 9600147A
- Authority
- EE
- Estonia
- Prior art keywords
- implantation
- host animal
- encapsulated cells
- encapsulated
- cells
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/13—Tumour cells, irrespective of tissue of origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0085—Brain, e.g. brain implants; Spinal cord
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/48—Nerve growth factor [NGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0613—Cells from endocrine organs
- C12N5/0614—Adrenal gland
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/02—Atmosphere, e.g. low oxygen conditions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- General Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/228,403 US5550050A (en) | 1994-04-15 | 1994-04-15 | Method for implanting encapsulated cells in a host |
PCT/US1995/004564 WO1995028166A2 (en) | 1994-04-15 | 1995-04-13 | Method for implanting encapsulated cells in a host |
Publications (1)
Publication Number | Publication Date |
---|---|
EE9600147A true EE9600147A (et) | 1997-04-15 |
Family
ID=22857036
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EE9600147A EE9600147A (et) | 1994-04-15 | 1995-04-13 | Kapseldatud rakkude peremeeslooma implanteerimise meetod |
Country Status (19)
Country | Link |
---|---|
US (1) | US5550050A (et) |
EP (2) | EP1632238A1 (et) |
JP (2) | JPH10501792A (et) |
CN (1) | CN1146155A (et) |
AU (1) | AU697600B2 (et) |
BR (1) | BR9507391A (et) |
CA (1) | CA2187335A1 (et) |
CZ (1) | CZ300496A3 (et) |
EE (1) | EE9600147A (et) |
FI (1) | FI964124A0 (et) |
HU (1) | HUT75661A (et) |
IL (1) | IL113390A0 (et) |
IS (1) | IS4368A (et) |
LV (1) | LV11730B (et) |
NO (1) | NO964358L (et) |
PL (1) | PL316845A1 (et) |
SK (1) | SK131696A3 (et) |
WO (1) | WO1995028166A2 (et) |
ZA (1) | ZA953126B (et) |
Families Citing this family (92)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993009176A2 (en) * | 1991-10-29 | 1993-05-13 | Clover Consolidated, Limited | Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release |
US5908623A (en) * | 1993-08-12 | 1999-06-01 | Cytotherapeutics, Inc. | Compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules |
US5858747A (en) * | 1994-07-20 | 1999-01-12 | Cytotherapeutics, Inc. | Control of cell growth in a bioartificial organ with extracellular matrix coated microcarriers |
US5935849A (en) * | 1994-07-20 | 1999-08-10 | Cytotherapeutics, Inc. | Methods and compositions of growth control for cells encapsulated within bioartificial organs |
US5620013A (en) * | 1994-10-21 | 1997-04-15 | American Cyanamid Company | Method for destroying residual lens epithelial cells |
US5762925A (en) * | 1994-11-03 | 1998-06-09 | Sagen; Jacqueline | Preventing opiate tolerance by cellular implantation |
US6495364B2 (en) | 1995-05-23 | 2002-12-17 | Neurotech, S.A. | Mx-1 conditionally immortalized cells |
US5855613A (en) | 1995-10-13 | 1999-01-05 | Islet Sheet Medical, Inc. | Retrievable bioartificial implants having dimensions allowing rapid diffusion of oxygen and rapid biological response to physiological change |
WO1997033912A2 (en) * | 1996-03-14 | 1997-09-18 | Genentech, Inc. | Uses of gdnf and gdnf receptor |
US5904144A (en) * | 1996-03-22 | 1999-05-18 | Cytotherapeutics, Inc. | Method for treating ophthalmic diseases |
US6299895B1 (en) | 1997-03-24 | 2001-10-09 | Neurotech S.A. | Device and method for treating ophthalmic diseases |
US6027721A (en) * | 1996-05-20 | 2000-02-22 | Cytotherapeutics, Inc. | Device and method for encapsulated gene therapy |
US6054142A (en) | 1996-08-01 | 2000-04-25 | Cyto Therapeutics, Inc. | Biocompatible devices with foam scaffolds |
US6150164A (en) * | 1996-09-30 | 2000-11-21 | The Regents Of The University Of Michigan | Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo |
US6074825A (en) * | 1997-07-31 | 2000-06-13 | Maine Medical Center | Stable encapsulated reference nucleic acid and method of making |
WO1999013868A1 (en) * | 1997-09-17 | 1999-03-25 | Alcon Laboratories, Inc. | Methods for treating ocular diseases |
WO1999013726A1 (en) * | 1997-09-19 | 1999-03-25 | University Of South Florida | Neuronal cells and an immunosuppressant and anti-inflammatory factor |
US6638501B1 (en) | 1997-09-29 | 2003-10-28 | Neurospheres Holdings Ltd. | Use of multipotent neural stem cell progeny to augment non-neural tissues |
US6303136B1 (en) | 1998-04-13 | 2001-10-16 | Neurotech S.A. | Cells or tissue attached to a non-degradable filamentous matrix encapsulated by a semi-permeable membrane |
US6184035B1 (en) | 1998-11-18 | 2001-02-06 | California Institute Of Technology | Methods for isolation and activation of, and control of differentiation from, skeletal muscle stem or progenitor cells |
US6610540B1 (en) * | 1998-11-18 | 2003-08-26 | California Institute Of Technology | Low oxygen culturing of central nervous system progenitor cells |
US6713293B1 (en) | 1999-02-08 | 2004-03-30 | Friedrich Grummt | Encapsulated cells containing an amplified expression vector as a drug delivery device |
AU772153B2 (en) * | 1999-02-12 | 2004-04-08 | Molecular Insight Pharmaceuticals, Inc. | Matrices for drug delivery and methods for making and using the same |
US6365385B1 (en) | 1999-03-22 | 2002-04-02 | Duke University | Methods of culturing and encapsulating pancreatic islet cells |
US6303355B1 (en) | 1999-03-22 | 2001-10-16 | Duke University | Method of culturing, cryopreserving and encapsulating pancreatic islet cells |
US6361771B1 (en) | 1999-04-06 | 2002-03-26 | Neurotech S.A. | ARPE-19 as a platform cell line for encapsulated cell-based delivery |
US20070071734A1 (en) * | 1999-04-06 | 2007-03-29 | Weng Tao | ARPE-19 as platform cell line for encapsulated cell-based delivery |
US20040213768A1 (en) * | 1999-04-30 | 2004-10-28 | Elliott Robert Bartlett | Preparation for biotransplantation and xenotransplantion and uses thereof |
US20090047325A1 (en) * | 1999-04-30 | 2009-02-19 | Neurotrophincell Pty. Limited | Xenotransplant for cns therapy |
EP1176970B1 (en) * | 1999-04-30 | 2010-05-19 | NeurotrophinCell Pty Ltd | Xenotransplant for cns therapy |
US20050265977A1 (en) * | 1999-04-30 | 2005-12-01 | Elliott Robert B | Xenotransplant for CNS therapy |
EP1248640B1 (en) * | 2000-01-20 | 2006-10-04 | Diabcell Pty Limited | Preparation and xenotransplantation of porcine islets |
WO2001054593A1 (en) * | 2000-01-31 | 2001-08-02 | The General Hospital Corporation | Neural regeneration conduit |
US6719970B1 (en) | 2000-07-10 | 2004-04-13 | Alkermes Controlled Therapeutics, Inc. | Method of generating cartilage |
WO2002032437A1 (en) * | 2000-10-17 | 2002-04-25 | Diatranz Limited | Preparation and xenotransplantation or porcine islets |
US6538010B1 (en) * | 2000-11-08 | 2003-03-25 | Research Triangle Institute | Compounds and methods for promoting smoking cessation |
CN1526011A (zh) * | 2001-07-10 | 2004-09-01 | IDECҩ�﹫˾ | 抑制凋亡过程及改善细胞性能 |
EP1281767A3 (en) | 2001-07-31 | 2003-05-28 | Aladar A. Szalay | Light emitting microorganisms and cells for diagnosis and therapy of tumors |
US7332330B2 (en) | 2001-09-11 | 2008-02-19 | Renamed Biologics, Inc. | Device for maintaining vascularization near an implant |
WO2003027270A1 (en) * | 2001-09-28 | 2003-04-03 | Diabcell Pty Limited | Growing xenotransplant material in culture |
US20030068308A1 (en) * | 2001-10-09 | 2003-04-10 | Jacek Rozga | Intrasplenic encapsulated cell therapy |
NZ515310A (en) * | 2001-11-07 | 2004-08-27 | Diabcell Pty Ltd | Methods of treatment and delivery modes |
US7442546B2 (en) * | 2002-03-15 | 2008-10-28 | The Regents Of The University Of Michigan | Method of modulating inflammatory response |
EP1369491A1 (en) * | 2002-06-05 | 2003-12-10 | Aladar A. Szalay | Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
US20030228261A1 (en) * | 2002-06-05 | 2003-12-11 | Aladar Szalay | Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
AU2002952993A0 (en) | 2002-11-29 | 2002-12-12 | The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland | Therapeutic and diagnostic agents |
AU2003901325A0 (en) * | 2003-03-21 | 2003-04-03 | Stephen Locarnini | Therapeutic, prophylactic and diagnostic agents |
US20070043512A1 (en) * | 2003-03-26 | 2007-02-22 | Michael Rolph | Therapeutic and prophylactic compositions and uses therefor |
AU2004245175C1 (en) | 2003-06-10 | 2010-03-18 | Biogen Ma Inc. | Improved secretion of neublastin |
DE602004018927D1 (de) * | 2003-06-18 | 2009-02-26 | Genelux Corp | Modifizierte rekombinante vacciniaviren, verwendungen davon |
CA2529573A1 (en) * | 2003-06-24 | 2004-12-29 | Diabcell Pty Limited | Porcine islets cultured with porcine sertoli cells for xenotransplantation |
WO2005020677A1 (en) | 2003-08-29 | 2005-03-10 | The Walter And Eliza Hall Institute Of Medical Research | Method of selecting animal models from animals which have been subject to mutagenesis, and the use of myb transcription factors for screening |
EP1677676A4 (en) * | 2003-09-05 | 2011-02-23 | Univ Ohio State Res Found | NANOTEILIC PROBE FOR IN VIVO MONITORING OF TISSUE OXYGENATION |
US8066973B2 (en) * | 2003-09-05 | 2011-11-29 | The Ohio State University Research Foundation | Nanoparticulate probe for in vivo monitoring of tissue oxygenation |
BRPI0415563A (pt) | 2003-10-20 | 2007-01-02 | Nsgene As | método para o tratamento do mal de parkinson, uso de um vetor viral, vetor de expressão viral, composição farmacêutica, célula hospedeira isolada, linhagem de células de empacotamento, mamìfero não humano quimérico, dispositivo de cultura celular implantável, cápsula biocompatìvel, método para tratamento de uma doença do sistema nervoso, célula de mamìfero, e, método para produzir neurturin ou um seu equivalente funcional |
AU2004292957C1 (en) * | 2003-11-13 | 2011-04-28 | Eyepoint Pharmaceuticals Us, Inc. | Injectable sustained release implant having a bioerodible matrix core and a bioerodible skin |
WO2005068498A2 (en) * | 2004-01-19 | 2005-07-28 | Nsgene A/S | Human therapeutic cells secreting nerve growth factor |
US20070281986A1 (en) * | 2004-02-03 | 2007-12-06 | Collier Gregory R | Methods and Compositions for Modulating Satiety |
DE602005014354D1 (de) | 2004-03-30 | 2009-06-18 | Nsgene As | Therapeutische verwendung des wachstumsfaktors nsg33 |
EP1766389A4 (en) | 2004-05-12 | 2008-08-27 | Inst Medical W & E Hall | CELL ISOLATION PROCEDURE |
WO2006013462A2 (en) * | 2004-07-30 | 2006-02-09 | Nsgene A/S | Growth factors nsg28, nsg30, and nsg32 |
CA2603391A1 (en) * | 2005-04-01 | 2006-10-05 | Nsgene A/S | A human immortalised neural precursor cell line |
WO2006122550A2 (en) * | 2005-05-17 | 2006-11-23 | Nsgene A/S | Storage container comprising an implantable therapy system |
NZ540597A (en) * | 2005-06-08 | 2007-02-23 | Neurotrophincell Pty Ltd | A method for preventing the onset of type I diabetes comprising administering an implantable composition comprising living choroid plexus cells |
CN101248177B (zh) | 2005-06-24 | 2012-09-05 | 沃尔特及伊莱萨霍尔医学研究院 | 治疗性促凋亡bh3样分子和用于产生和/或选择它的方法 |
CA2627543A1 (en) * | 2005-10-28 | 2007-05-03 | Ns Gene A/S | Implantable biocompatible immttnoisolatory vehicle for delivery of gdnf |
DE102005061801A1 (de) * | 2005-12-23 | 2007-06-28 | BSH Bosch und Siemens Hausgeräte GmbH | Einschubdosiersystem für Haushaltsgeräte |
WO2007078922A2 (en) * | 2005-12-30 | 2007-07-12 | Neurotech Usa Inc. | Micronized device for the delivery of biologically active molecules and methods of use thereof |
TW200819540A (en) | 2006-07-11 | 2008-05-01 | Genelux Corp | Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders |
EP2051726B1 (en) | 2006-07-18 | 2018-04-18 | University of Utah Research Foundation | Methods for treating pain and screening analgesic compounds |
EP2205249B1 (en) | 2007-09-28 | 2018-11-07 | Intrexon Corporation | Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof |
US20090090214A1 (en) * | 2007-10-04 | 2009-04-09 | Chung Yuan Christian University | Method for forming nano-scale metal particles |
US20090196854A1 (en) * | 2008-02-04 | 2009-08-06 | Kytos Biosystems S.A. | Methods and compositions for use of crl 5803 cells for expression of biotherapeutics and encapsulated cell-based delivery |
US20100021437A1 (en) * | 2008-04-07 | 2010-01-28 | The McLean Hospital Corporation Whitehead Institute for Biomedical Research | Neural stem cells derived from induced pluripotent stem cells |
US20120021039A1 (en) | 2009-01-23 | 2012-01-26 | Nsgene A/S | Expression of neuropeptides in mammalian cells |
AU2010206374B2 (en) | 2009-01-23 | 2013-01-17 | Gloriana Therapeutics Sarl | Improved cell lines and their use in encapsulated cell biodelivery |
US20150024024A1 (en) * | 2009-04-23 | 2015-01-22 | Neurotech Usa, Inc. | Cell Lines That Produce Prostaglandin F2 Alpha (PGF2A) And Uses Thereof |
FR2948125B1 (fr) | 2009-07-17 | 2011-08-26 | Zoran Dermanovic | Procedes d'etablissement de symbioses |
US20110091427A1 (en) * | 2009-10-02 | 2011-04-21 | Baxter International Inc. | Methods for treating a kidney injury |
JP2013507373A (ja) * | 2009-10-08 | 2013-03-04 | ニューロテック ユーエスエー, インコーポレイテッド | 被包された細胞ベースの送達系におけるpedfの使用 |
EP2621512B1 (en) | 2010-10-01 | 2016-04-06 | NsGene A/S | Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain |
AU2011336592A1 (en) | 2010-12-02 | 2013-07-11 | Neurotech Usa, Inc. | Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors and uses thereof |
JP2012215543A (ja) * | 2011-03-31 | 2012-11-08 | Sony Corp | 個体情報の判定方法、個体情報判定装置、電子機器及び個体情報判定プログラム |
JP6145667B2 (ja) | 2011-09-05 | 2017-06-14 | ホーバ セラピューティクス アンパルトセルスカブ | アロディニア、痛覚過敏、自発痛、及び幻痛の治療 |
EP2817014A2 (en) | 2012-02-21 | 2014-12-31 | Baxter International Inc | Pharmaceutical composition comprising cd34+ cells |
US20150150796A1 (en) | 2012-05-30 | 2015-06-04 | Neurotech Usa, Inc. | Cryopreserved Implantable Cell Culture Devices and Uses Thereof |
AU2014225352B2 (en) | 2013-03-07 | 2017-02-09 | Viacyte, Inc. | 3-dimensional large capacity cell encapsulation device assembly |
MX367858B (es) | 2013-05-31 | 2019-09-09 | Univ Utah Res Found | Péptidos de conotoxina, composiciones farmacéuticas y usos de los mismos. |
WO2015038669A1 (en) | 2013-09-11 | 2015-03-19 | Neurotech Usa, Inc. | Encapsulated cell therapy cartridge |
JP6850734B2 (ja) | 2015-05-27 | 2021-03-31 | ニューロテック ユーエスエー, インコーポレイテッド | 眼の障害の処置のためのカプセル化細胞療法の使用 |
CA3003294A1 (en) | 2015-10-27 | 2017-05-04 | The University Of Queensland | Modified epha4 and uses thereof |
WO2022011081A1 (en) | 2020-07-09 | 2022-01-13 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Cell lines that produce human retinoschisin proteins and uses thereof |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4409331A (en) * | 1979-03-28 | 1983-10-11 | Damon Corporation | Preparation of substances with encapsulated cells |
US4352883A (en) * | 1979-03-28 | 1982-10-05 | Damon Corporation | Encapsulation of biological material |
US4298002A (en) * | 1979-09-10 | 1981-11-03 | National Patent Development Corporation | Porous hydrophilic materials, chambers therefrom, and devices comprising such chambers and biologically active tissue and methods of preparation |
US4353888A (en) * | 1980-12-23 | 1982-10-12 | Sefton Michael V | Encapsulation of live animal cells |
NO163060C (no) * | 1981-03-13 | 1990-03-28 | Damon Biotech Inc | Fremgangsmaate for fremstilling av substanser som dannes av levende celler som produserer interferoner eller antistoffer. |
JPS5876086A (ja) * | 1981-10-28 | 1983-05-09 | Ajinomoto Co Inc | 浮遊性動物細胞の培養法 |
US4479796A (en) * | 1982-11-15 | 1984-10-30 | Medtronic, Inc. | Self-regenerating drug administration device |
EP0127989A3 (en) * | 1983-06-01 | 1986-03-26 | Connaught Laboratories Limited | Microencapsulation of living tissue and cells |
US4689293A (en) * | 1983-06-06 | 1987-08-25 | Connaught Laboratories Limited | Microencapsulation of living tissue and cells |
US4806355A (en) * | 1983-06-06 | 1989-02-21 | Connaught Laboratories Limited | Microencapsulation of living tissue and cells |
JPS60141286A (ja) * | 1983-12-28 | 1985-07-26 | Ajinomoto Co Inc | 動物細胞の培養方法および装置 |
US4749620A (en) * | 1984-02-15 | 1988-06-07 | Massachusetts Institute Of Technology | Encapsulated active material system |
CA1215922A (en) * | 1984-05-25 | 1986-12-30 | Connaught Laboratories Limited | Microencapsulation of living tissue and cells |
GB8500121D0 (en) * | 1985-01-03 | 1985-02-13 | Connaught Lab | Microencapsulation of living cells |
US4868121A (en) | 1985-02-07 | 1989-09-19 | Mcdonnell Douglas Corporation | Islet isolation process |
US4902295A (en) * | 1985-08-26 | 1990-02-20 | Hana Biologics, Inc. | Transplantable artificial tissue |
US4753635A (en) | 1986-05-23 | 1988-06-28 | Jacqueline Sagen | Inducing analgesia by implantation of cells releasing neuroactive substances |
US5026365A (en) * | 1987-04-29 | 1991-06-25 | The University Of Massachusetts | Method and apparatus for therapeutically treating immunological disorders and disease states |
DE3724798A1 (de) * | 1987-07-27 | 1989-02-09 | Mengele & Soehne Masch Karl | Erntevorsatz an feldhaeckslern |
US4942129A (en) * | 1987-07-28 | 1990-07-17 | Queen's University At Kingston | Multiple membrane microencapsulation |
US5158881A (en) | 1987-11-17 | 1992-10-27 | Brown University Research Foundation | Method and system for encapsulating cells in a tubular extrudate in separate cell compartments |
US5283187A (en) | 1987-11-17 | 1994-02-01 | Brown University Research Foundation | Cell culture-containing tubular capsule produced by co-extrusion |
US5106627A (en) * | 1987-11-17 | 1992-04-21 | Brown University Research Foundation | Neurological therapy devices |
US5182111A (en) * | 1987-11-17 | 1993-01-26 | Boston University Research Foundation | In vivo delivery of active factors by co-cultured cell implants |
US4892538A (en) * | 1987-11-17 | 1990-01-09 | Brown University Research Foundation | In vivo delivery of neurotransmitters by implanted, encapsulated cells |
KR0132666B1 (en) * | 1989-03-14 | 1998-04-14 | Hitachi Kk | Method for controlling cultivation conditions for animal cells |
US5002661A (en) * | 1989-08-25 | 1991-03-26 | W. R. Grace & Co.-Conn. | Artificial pancreatic perfusion device |
WO1991009119A1 (en) * | 1989-12-13 | 1991-06-27 | Trancel Corporation | Improved alginate microcapsules, methods of making and using same |
WO1991010470A1 (en) * | 1990-01-08 | 1991-07-25 | Brown University Research Foundation | Devices and methods for enhanced delivery of active factors |
US5084350A (en) * | 1990-02-16 | 1992-01-28 | The Royal Institution For The Advance Of Learning (Mcgill University) | Method for encapsulating biologically active material including cells |
CA2089582A1 (en) | 1990-08-15 | 1992-02-16 | Richard P. Bunge | Autotransplantation of schwann cells to promote nervous system repair |
JP4215273B2 (ja) * | 1991-04-25 | 2009-01-28 | ブラウン ユニヴァーシティ リサーチ ファンデーション | 選択された治療物質放出用の移植可能で生体適合性の免疫遮断性ビークル |
CA2090720C (en) | 1991-06-28 | 1998-08-18 | Patrick Aebischer | Neural implant system |
JPH07505786A (ja) * | 1992-04-24 | 1995-06-29 | ソマティクス セラピー コーポレイション | 生存可能な細胞の培養法および体液中の化合物濃度の調整法 |
CA2140905A1 (en) | 1992-07-29 | 1994-01-30 | Keith E. Dionne | Use of pouch of implantation of living cells |
CN1129402A (zh) | 1993-06-23 | 1996-08-21 | 布朗大学研究基金会 | 密封可植入的薄膜封装件的方法和装置 |
AU7568094A (en) | 1993-08-12 | 1995-03-14 | Cytotherapeutics, Inc. | Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules |
-
1994
- 1994-04-15 US US08/228,403 patent/US5550050A/en not_active Expired - Lifetime
-
1995
- 1995-04-13 JP JP7527082A patent/JPH10501792A/ja active Pending
- 1995-04-13 WO PCT/US1995/004564 patent/WO1995028166A2/en not_active Application Discontinuation
- 1995-04-13 EP EP05023484A patent/EP1632238A1/en not_active Withdrawn
- 1995-04-13 PL PL95316845A patent/PL316845A1/xx unknown
- 1995-04-13 SK SK1316-96A patent/SK131696A3/sk unknown
- 1995-04-13 CZ CZ963004A patent/CZ300496A3/cs unknown
- 1995-04-13 EE EE9600147A patent/EE9600147A/et unknown
- 1995-04-13 BR BR9507391A patent/BR9507391A/pt not_active Application Discontinuation
- 1995-04-13 CN CN95192579A patent/CN1146155A/zh active Pending
- 1995-04-13 CA CA002187335A patent/CA2187335A1/en not_active Abandoned
- 1995-04-13 AU AU23829/95A patent/AU697600B2/en not_active Ceased
- 1995-04-13 EP EP95916970A patent/EP0756487A1/en not_active Ceased
- 1995-04-13 HU HU9602850A patent/HUT75661A/hu unknown
- 1995-04-14 IL IL11339095A patent/IL113390A0/xx unknown
- 1995-04-18 ZA ZA953126A patent/ZA953126B/xx unknown
-
1996
- 1996-10-01 IS IS4368A patent/IS4368A/is unknown
- 1996-10-14 FI FI964124A patent/FI964124A0/fi unknown
- 1996-10-14 NO NO964358A patent/NO964358L/no not_active Application Discontinuation
- 1996-11-15 LV LVP-96-434A patent/LV11730B/en unknown
-
2005
- 2005-03-16 JP JP2005076076A patent/JP2005239726A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US5550050A (en) | 1996-08-27 |
NO964358D0 (no) | 1996-10-14 |
CA2187335A1 (en) | 1995-10-26 |
MX9604832A (es) | 1998-06-28 |
SK131696A3 (en) | 1997-06-04 |
HU9602850D0 (en) | 1996-12-30 |
WO1995028166A3 (en) | 1995-11-09 |
AU2382995A (en) | 1995-11-10 |
IL113390A0 (en) | 1995-07-31 |
EP1632238A1 (en) | 2006-03-08 |
ZA953126B (en) | 1996-01-04 |
AU697600B2 (en) | 1998-10-08 |
NO964358L (no) | 1996-12-13 |
PL316845A1 (en) | 1997-02-17 |
FI964124A (fi) | 1996-10-14 |
FI964124A0 (fi) | 1996-10-14 |
HUT75661A (en) | 1997-05-28 |
CZ300496A3 (en) | 1997-03-12 |
EP0756487A1 (en) | 1997-02-05 |
JPH10501792A (ja) | 1998-02-17 |
IS4368A (is) | 1996-10-01 |
BR9507391A (pt) | 1997-09-16 |
LV11730A (lv) | 1997-04-20 |
LV11730B (en) | 1998-02-20 |
JP2005239726A (ja) | 2005-09-08 |
WO1995028166A2 (en) | 1995-10-26 |
CN1146155A (zh) | 1997-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE9600147A (et) | Kapseldatud rakkude peremeeslooma implanteerimise meetod | |
FI970217A0 (fi) | Keinotekoisiin biologisiin välineisiin kapseloitujen solujen kasvun säätely | |
FI102426B1 (fi) | Menetelmä muistin toteuttamiseksi | |
FI102424B1 (fi) | Menetelmä muistin toteuttamiseksi | |
DE69329420D1 (de) | In situ implantierter biologischer stromgenerator | |
NZ230923A (en) | Transponder for implantation in animal: plastics casing resists migration | |
SG47996A1 (en) | Method for culturing animal cells under embedded conditions | |
DE69518253T2 (de) | Speicherkanteverbinder und seine anwendungsmethode | |
FI102425B1 (fi) | Menetelmä muistin toteuttamiseksi | |
KR960012687A (ko) | 발전설비 및 그 제어방법 | |
DK0804068T3 (da) | Kunstigt bosted for hummere | |
EP0756003A4 (en) | METHOD FOR CULTIVATING ANIMAL CELLS | |
EP1003849A4 (en) | METHOD FOR REDUCING THE EXPRESSION VARIANCE OF TRANSGENES IN PLANT CELLS | |
IT1292498B1 (it) | Metodo ed impianto per la mitilicoltura | |
PH31336A (en) | Method for implanting encapsulated cells in a host. | |
FI961467A (fi) | Sähkökemiallinen menetelmä | |
DE9408154U1 (de) | Implantationsset | |
AUPO922897A0 (en) | A method of treatment and an animal model useful for same | |
DK515587D0 (da) | Protese til implantation i et kranium | |
KR920001726A (ko) | 메모리 셀 제조방법 | |
KR970041597U (ko) | 이씨유 전원 공급 장치 및 그 제어 방법 | |
KR950029623U (ko) | 동물모형 조립구 | |
BR7600422U (pt) | Método anticoncepcional natural | |
KR950029109U (ko) | 양봉용 소초 | |
ITPD970109A1 (it) | Metodo di cura |